Morfología y Biología Celular
Departament
ALEJANDRO
LOPEZ SOTO
Profesor Titular de Universidad
Publicacions en què col·labora amb ALEJANDRO LOPEZ SOTO (17)
2023
-
BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia
Cancer Immunology, Immunotherapy, Vol. 72, Núm. 7, pp. 2529-2539
2022
-
Autophagy-linked plasma and lysosomal membrane protein PLAC8 is a key host factor for SARS-CoV-2 entry into human cells
EMBO Journal, Vol. 41, Núm. 21
2021
2020
-
A cytofluorimetric assay to evaluate intracellular cytokine production by NK cells
Methods in Enzymology (Academic Press Inc.), pp. 343-355
-
Evaluation of NK cell cytotoxic activity against malignant cells by the calcein assay
Methods in Enzymology (Academic Press Inc.), pp. 483-495
-
Mechanisms of apoptosis resistance to NK cell-mediated cytotoxicity in cancer
International Journal of Molecular Sciences, Vol. 21, Núm. 10
-
Mechanisms of resistance to NK cell immunotherapy
Cancers, Vol. 12, Núm. 4
2019
-
A flow cytometric NK cell-mediated cytotoxicity assay to evaluate anticancer immune responses In vitro
Methods in Molecular Biology (Humana Press Inc.), pp. 131-139
-
CD107a degranulation assay to evaluate immune cell antitumor activity
Methods in Molecular Biology (Humana Press Inc.), pp. 119-130
-
Immunosurveillance of cancer cell stress
Cell Stress, Vol. 3, Núm. 9, pp. 295-309
-
NK cell-based immunotherapy in cancer metastasis
Cancers, Vol. 11, Núm. 1
-
The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling
Frontiers in Immunology, Vol. 10
2018
-
Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia
Frontiers in immunology, Vol. 9, pp. 2917
2017
-
Biallelic IRF8 Mutations Causing NK Cell Deficiency
Trends in Molecular Medicine
-
Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia
OncoImmunology, Vol. 6, Núm. 10
2016
-
Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors
OncoImmunology, Vol. 5, Núm. 2